|
1
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer.
37:S4–S66. 2001.PubMed/NCBI
|
|
3
|
Wang WL, London WT, Lega L and Feitelson
MA: HBxAg in the liver from carrier patients with chronic hepatitis
and cirrhosis. Hepatology. 14:29–37. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang H, Oishi N, Kaneko S and Murakami S:
Molecular functions and biological roles of hepatitis B virus x
protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sirma H, Giannini C, Poussin K, Paterlini
P, Kremsdorf D and Bréchot C: Hepatitis B virus X mutants, present
in hepatocellular carcinoma tissue abrogate both the
antiproliferative and transactivation effects of HBx. Oncogene.
18:4848–4859. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu DY, Moon HB, Son JK, et al: Incidence
of hepatocellular carcinoma in transgenic mice expressing the
hepatitis B virus X-protein. J Hepatol. 31:123–132. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu XH, Lin J, Zhang SH, et al:
COOH-terminal deletion of HBx gene is a frequent event in
HBV-associated hepatocellular carcinoma. World J Gastroenterol.
14:1346–1352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma NF, Lau SH, Hu L, et al: COOH-terminal
truncated HBV X protein plays key role in hepatocarcinogenesis.
Clin Cancer Res. 14:5061–5068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Budhu A, Jia HL, Forgues M, et al:
Identification of metastasis-related micro-RNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar
|
|
11
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: Micro-RNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang J, Wang Y, Guo Y and Sun S:
Downregulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu P, Tan D, Peng Z, Liu F and Song L:
Polymorphism analyses of hepatitis B virus X gene in hepatocellular
carcinoma patients from southern China. Acta Biochim Biophys Sin
(Shanghai). 39:265–272. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boyle P and Levin B: World Cancer Report
2008. International Agency for Research on Cancer; Lyons, France:
pp. 338–343. 2008
|
|
15
|
Andrisani OM and Barnabas S: The role of
the transcriptional involvement of HBV pX in hepatocarcinogenesis
(Review). Int J Oncol. 15:373–139. 1999.
|
|
16
|
Chen HY, Tang NH, Lin N, Chen ZX and Wang
XZ: Hepatitis B virus X protein induces apoptosis and cell cycle
deregulation through interfering with DNA repair and checkpoint
responses. Hepatol Res. 38:174–182. 2008.PubMed/NCBI
|
|
17
|
Chen S, Zhao W, Tan W, et al: Association
of TBX21 T-1993C polymorphism with viral persistence but not
disease progression in hepatitis B virus carrier. Hepatol Res.
39:716–723. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carleton M, Cleary MA and Linsley PS:
MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vebtura A and Jacka T: MicroRNAs and
cancer: short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masaki T: MicroRNA and hepatocellular
carcinoma. Hepatol Res. 39:751–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang XH, Wang Q, Chen JS, et al:
Bead-based microarray analysis of microRNA expression in
hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res.
39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simon DJ, Madison JM, Conery AL, et al:
The microRNA miR-1 regulates a MEF-2 dependent retrograde signal at
neuromuscular junctions. Cell. 133:903–915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nasser MW, Datta J, Nuovo G, et al:
Downregulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sarver AL, French AJ, Borralho PM, et al:
Human colon cancer profiles show differential MicroRNA expression
depending on mismatch repair status and are characteristic of
undifferentiated proliferative states. BMC Cancer. 9:4012009.
View Article : Google Scholar
|
|
25
|
Datta J, Kutay H, Nasser MW, et al:
Methylation mediated silencing of Micro-RNA-1 gene and its role in
hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jung JK, Arora P, Pagano JS and Jang KL:
Expression of DNA methyltransferase 1 is activated by hepatitis B
virus X protein via a regulatory circuit involving the
p16INK4a-cyclin D1-CDK4/6-pRb-E2F1 pathway. Cancer Res.
67:5771–5778. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu J, Ohuchida K, Mizumoto K, et al:
MicroRNA, hsa-miR-200c, is an independent prognostic factor in
pancreatic cancer and its upregulation inhibits pancreatic cancer
invasion but increases cell proliferation. Mol Cancer. 9:1692010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the MicroRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang SZ, Zhang LD, Zhang Y, et al: HBx
protein induces EMT through c-Src activation in SMMC-7721 hepatoma
cell line. Biochem Biophys Res Commun. 382:555–560. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vrba L, Jensen TJ, Garbe JC, et al: Role
for DNA methylation in the regulation of miR-200c and miR-141
expression in normal and cancer cells. PLoS One. 5:e86972010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pekarsky Y, Santanam U, Cimmino A, et al:
Tcl1 expression in chronic lymphocytic leukemia is regulated by
miR-29 and miR-181. Cancer Res. 66:11590–11593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fabbri M, Garzon R, Cimmino A, et al:
MicroRNA-29 family reverts aberrant methylation in lung cancer by
targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S
A. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park SY, Lee JH, Ha M, Nam JW and Kim VN:
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat
Struct Mol Biol. 16:23–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kefas B, Godlewski L, Comeau L, et al:
MicroRNA-7 inhibits the epidermal growth factor receptor and the
Akt pathway and is downregulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Silber J, Lim DA, Petritsch C, et al:
miR-124 and miR-137 inhibit proliferation of glioblastoma
multiforme cells and induce differentiation of brain tumor stem
cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takada Y, Murakami A and Aggarwal BB:
Zerumbone abolishes NF-κB and IκBα kinase activation leading to
suppression of antiapoptotic and metastatic gene expression,
upregulation of apoptosis and downregulation of invasion. Oncogene.
24:6957–6969. 2005.
|
